The U.S. government is set to cease the distribution of free doses of Merck & Co Inc's (NYSE: MRK) COVID-19 antiviral treatment Lagevrio (molnupiravir), by mid-November, shifting its availability to the commercial market.
Belgium's intelligence service closely monitors the European logistics hub of Alibaba Group Holding Ltd (NYSE: BABA) as concerns of potential espionage and data misuse linked to the Chinese retail giant.